The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
Adani Ports and SEZ
Ind-Swift Laboratories Ltd. Share Price
Pharmaceuticals & DrugsInd-Swift Laboratories Ltd. (INR)103.350.9 (0.9%) 
Exchange ScripsBSE532305NSEINDSWFTLABISININE915B01019
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Ind-Swift Laboratories Ltd. Performance
Market performance
Open price102.4
High107.7
Volumes221336
Prev Close103.35
Low100.99
Closing date2025-06-18
Historical performance
1 Year High186.00
3 Year High186.00
5 Year High186.00
1 Year Low68.72
3 Year Low52.65
5 Year Low31.40
Ind-Swift Laboratories Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
NaN
Face Value (₹)
P/E Ratio
Dividend Yield
N/A
Ind-Swift Laboratories Ltd. Investment Returns
1 Year
-10.5%
3 Years
71.8%
5 Years
157.1%
10 Years
221.5%
Ind-Swift Laboratories Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 105.98 | Bearish |
| 10-DMA | 102.01 | Bullish |
| 20-DMA | 91.36 | Bullish |
| 50-DMA | 83.47 | Bullish |
| 100-DMA | 89.62 | Bullish |
| 200-DMA | 103.69 | Bearish |
Shareholding Pattern
| Field | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
| Promoters | 18 | 18 | 18 | 18 | 18 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 18 | 18 | 18 | 18 | 18 |
| Public Investors | 28099 | 28734 | 28865 | 25443 | 22421 |
| Government | --- | --- | --- | --- | --- |
Ind-Swift Laboratories Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 454 | 335 | 435 | 227 |
| Operating Profit | 2996 | 2627 | 2391 | 2055 |
| Interest | 511 | 922 | 955 | 1002 |
| Depreciation | 533 | 574 | 1310 | 873 |
| Profit Before Tax | 5818 | 865 | 125 | 180 |
| Consolidated Net Profit | 4210 | 476 | -21 | -31 |
| Adjusted EPS | 71 | 8 | --- | -1 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 591 | 598 | 598 | 598 |
| Total Reserves | 8724 | 6221 | 5412 | 5437 |
| Minority Interest | --- | --- | -1 | -1 |
| Total Non-Current Liabilities | -195 | 7412 | 8136 | 8402 |
| Total Liabilities | 11332 | 17942 | 17489 | 17581 |
| Capital Work in Progress | --- | 77 | 93 | 107 |
| Total Assets | 11332 | 17942 | 17489 | 17581 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | -1631 | 1946 | 1503 | 1349 |
| Cash Flow from Investing Activities | -1043 | -134 | 48 | -102 |
| Cash Flow from Financing Activitie | 6807 | -1857 | -1409 | -1237 |
| Net Cash Inflow / Outflow | 4133 | -44 | 142 | 10 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 1.45.
- 3Y Stock Price CAGR of the stock is 21.1.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹2996 Million.
- The company generated revenue of ₹12809 Million in the previous financial year.
Ind-Swift Laboratories Ltd.
103.350.9 (0.9%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 922356.1
No. of Shares: 8924.6
Performance:-7.8%
P/L: ₹-77643.9
Top Gainers
| Symbol | Change% |
|---|---|
| EMIL | 158.37(18%) |
| SILLYMONKS | 18(14%) |
| OPTIEMUS | 684.6(11%) |
| AAKASH | 9.7(11%) |
| PFOCUS | 130.98(10%) |
Similar stocks
Announcing Stock of the Month!
Live video call With Our Agent